About DT.BIOTECH INNOV.AG O.N.
Sector
Industry
CEO
Bernd Wegener
Website
Headquarters
Hennigsdorf
Founded
2009
ISIN
DE000A0Z25L1
FIGI
BBG000QYZF40
Deutsche Biotech Innovativ AG invests in biotechnology companies that focus on research and development; as well as develop drug agents for vascular integrity improvement, solid tumors, and antibody-based therapy for the treatment of organ failure in patients with cardiogenic shock. The company was founded by Bernd Wegener and Andreas Bergmann in 2009 and is headquartered in Hennigsdorf, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on DUS exchange DT.BIOTECH INNOV.AG O.N. stocks are traded under the ticker DBI.
Yes, you can track DT.BIOTECH INNOV.AG O.N. financials in yearly and quarterly reports right on TradingView.
No, DBI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DBI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DT.BIOTECH INNOV.AG O.N. stock right from TradingView charts — choose your broker and connect to your account.